Karl Wegscheider

Active 1983–2026

164
Papers
27,023
Citations
93
h-index
162
i10-index

Citations

Citations per year for Karl Wegscheider1916: 1 citations1981: 1 citations1983: 2 citations1984: 7 citations1985: 11 citations1986: 10 citations1987: 4 citations1988: 7 citations1989: 2 citations1990: 2 citations1992: 8 citations1993: 4 citations1994: 4 citations1995: 8 citations1996: 13 citations1997: 12 citations1998: 9 citations1999: 13 citations2000: 18 citations2001: 26 citations2002: 22 citations2003: 18 citations2004: 37 citations2005: 46 citations2006: 36 citations2007: 52 citations2008: 64 citations2009: 64 citations2010: 92 citations2011: 88 citations2012: 149 citations2013: 135 citations2014: 161 citations2015: 174 citations2016: 212 citations2017: 214 citations2018: 180 citations2019: 651 citations2020: 722 citations2021: 799 citations2022: 692 citations2023: 563 citations2024: 999 citations2025: 373 citations2026: 22 citations1917–1980: no citations, so these years are not shown1982: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,961 citing papers, 17.4% of this breakdownGermany: 1,322 citing papers, 11.7% of this breakdownUnited Kingdom: 954 citing papers, 8.5% of this breakdownItaly: 557 citing papers, 4.9% of this breakdownNetherlands: 508 citing papers, 4.5% of this breakdownCanada: 485 citing papers, 4.3% of this breakdownChina: 482 citing papers, 4.3% of this breakdownAustralia: 428 citing papers, 3.8% of this breakdownFrance: 413 citing papers, 3.7% of this breakdownSpain: 365 citing papers, 3.2% of this breakdownSwitzerland: 327 citing papers, 2.9% of this breakdownBelgium: 276 citing papers, 2.4% of this breakdown
0%17.4%Other 28.4%

Fields

  • Medicine79.9%
  • Health Professions4.1%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Psychology2.9%
  • Immunology and Microbiology2.2%
  • Neuroscience2.2%
  • Other5.1%

Topics

  • Atrial Fibrillation Management and Outcomes6.1%
  • Cardiac Arrhythmias and Treatments4.5%
  • Cardiac pacing and defibrillation studies2.9%
  • Obstructive Sleep Apnea Research2.8%
  • Cardiac electrophysiology and arrhythmias2.6%
  • Cancer survivorship and care2.5%
  • Other78.6%

Coauthors

All papers

Open in search
  1. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 2,095

  2. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2018 cited by 740

  3. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial

    Authors: , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 732

  4. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dipak Kotecha, Michael Krekler, Christophe Leclercq, Thorsten Lewalter, Honghuang Lin, Dominik Linz, Gregory Y.H. Lip, Maja Lisa Løchen, Wim A M Lucassen, Katarzyna Małaczyńska-Rajpold, Steffen Maßberg, José Luís Merino, Ralf Meyer, Lluı́s Mont, Michael C. Myers, Lis Neubeck, Teemu Niiranen, M. Oeff, Jonas Oldgren, Tatjana Potpara, George Psaroudakis, Helmut Pürerfellner, Ursula Ravens, Michiel Rienstra, Léna Rivard, Daniel Scherr, Ulrich Schotten, Dipen Shah, Moritz F. Sinner, Rüdiger Smolnik, Gerhard Steinbeck, Daniel Steven, Emma Svennberg, Dierk Thomas, Mellanie True Hills, Isabelle C. Van Gelder, Burcu Vardar, Elena Palà, Reza Wakili, Karl Wegscheider, Mattias Wieloch, Stephan Willems, Henning Witt, André Ziegler, Matthias Daniel Zink, Paulus Kirchhof - EP Europace 2022 cited by 178

  5. One in two cancer patients is significantly distressed: Prevalence and indicators of distress

    Authors: , , , , , , , , , , , - Psycho-Oncology 2017 cited by 627

  6. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure

    Authors: , , , , , , , , , , - New England Journal of Medicine 2015 cited by 1,084

  7. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 240

  8. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 cited by 183

  9. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial

    Authors: , , , , , , , , , , , - European Heart Journal 2022 cited by 110

  10. Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure

    Authors: , , , , , , , , , , , , , , , - JACC. Clinical electrophysiology 2021 cited by 199

  11. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial

    Authors: , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2014 cited by 806

  12. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden

    Authors: , , , , , , , , , , , , - Circulation 2022 cited by 120

  13. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. Christoph Geller, Evgeny Pokushalov, Klaus‐Jürgen Gutleben, P Sommer, Leif‐Hendrik Boldt, Abdul Shokor Parwani - Circulation 2020 cited by 185

  14. Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 638

  15. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients

    Authors: , , , , , , , - European Heart Journal 2015 cited by 303

  16. The Generalized Anxiety Disorder Screener (GAD‐7) and the anxiety module of the Hospital and Depression Scale (HADS‐A) as screening tools for generalized anxiety disorder among cancer patients

    Authors: , , , , , , , , , , , , - Psycho-Oncology 2018 cited by 187

  17. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

    Authors: , , , , , , , , , , , - Clinical Research in Cardiology 2016 cited by 139

  18. Defibrillator Implantation Early after Myocardial Infarction

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 686

  19. Prevalence of mental disorders in elderly people: The European MentDis_ICF65+ study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The British Journal of Psychiatry 2016 cited by 427

  20. Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions

    Authors: , , , , , , , , , - PLoS ONE 2010 cited by 394

  21. Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation

    Authors: , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2016 cited by 260

  22. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - EP Europace 2021 cited by 49

  23. Satisfaction with information and unmet information needs in men and women with cancer

    Authors: , , , , , , , , , , , , , , , - Journal of Cancer Survivorship 2015 cited by 226

  24. Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial

    Authors: , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2011 cited by 186